A Novel Role of Sodium Butyrate in the Regulation of Cancer-associated Aromatase Promoters I.3 and II by Disrupting a Transcriptional Complex in Breast Adipose Fibroblasts
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The aromatase gene encodes the key enzyme for estrogen formation. Aromatase enzyme inhibitors eliminate total body estrogen production and are highly effective therapeutics for postmenopausal breast cancer. A distal promoter (I.4) regulates low levels of aromatase expression in tumor-free breast adipose tissue. Two proximal promoters (I.3/II) strikingly induce in vivo aromatase expression in breast fibroblasts surrounding malignant cells. Treatment of breast fibroblasts with medium conditioned with malignant breast epithelial cells (MCM) or a surrogate hormonal mixture (dibutyryl (Bt2)cAMP plus phorbol diacetate (PDA)) induces promoters I.3/II. The mechanism of promoter-selective expression, however, is not clear. Here we reported that sodium butyrate profoundly decreased MCM- or Bt2cAMP + PDA-induced promoter I.3/II-specific aromatase mRNA. MCM, Bt2cAMP + PDA, or sodium butyrate regulated aromatase mRNA or activity only via promoters I.3/II but not promoters I.1 or I.4 in breast, ovarian, placental, and hepatic cells. Mechanistically, recruitment of phosphorylated ATF-2 by a CRE (-211/-199, promoter I.3/II) conferred inductions by MCM or Bt2cAMP + PDA. Chromatin immunoprecipitation-PCR and immunoprecipitation-immunoblotting assays indicated that MCM or Bt2cAMP + PDA stabilized a complex composed of phosphorylated ATF-2, C/EBPbeta, and cAMP-response element-binding protein (CREB)-binding protein in the common regulatory region of promoters I.3/II. Overall, histone acetylation patterns of promoters I.3/II did not correlate with sodium butyrate-dependent silencing of promoters I.3/II. Sodium butyrate, however, consistently disrupted the activating complex composed of phosphorylated ATF-2, C/EBPbeta, and CREB-binding protein. This was mediated, in part, by decreased ATF-2 phosphorylation. Together, these findings represent a novel mechanism of sodium butyrate action and provide evidence that aromatase activity can be ablated in a signaling pathway- and cell-specific fashion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032312 · Cited by 1,795
Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., Jones, S. E., Alvarez, I., Bertelli, G., Ortmann, O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040331 · Cited by 1,759
Bulun, S. E., Lin, Z., Imir, G., Amin, S., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., Gurates, B., et al. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.3.6 · Cited by 531
Self-citationHEMSELL, D. L., GRODIN, J. M., BRENNER, P. F., SIITERI, P. K., & MACDONALD, P. C. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-3-476 · Cited by 444
McNATTY, K. P., BAIRD, D. T., BOLTON, A., CHAMBERS, P., CORKER, C. S., & McLEAN, H. (1976) · Journal of Endocrinology · doi:10.1677/joe.0.0710077 · Cited by 235
Recruitment of CREB Binding Protein Is Sufficient for CREB-Mediated Gene Activation
Cardinaux, J.-R., Notis, J. C., Zhang, Q., Vo, N., Craig, J. C., Fass, D. M., Brennan, R. G., & Goodman, R. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1546-1552.2000 · Cited by 162
Estrogen Excess Associated with Novel Gain-of-Function Mutations Affecting the Aromatase Gene
Shozu, M., Sebastian, S., Takayama, K., Hsu, W.-T., Schultz, R. A., Neely, K., Bryant, M., & Bulun, S. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021559 · Cited by 158
Self-citationSteinkampf, M. P., Mendelson, C. R., & Simpson, E. R. (1987) · Molecular Endocrinology · doi:10.1210/mend-1-7-465 · Cited by 135
Butyrate-Induced Differentiation of Colon Cancer Cells Is PKC and JNK Dependent
Orchel, A., Dzierżewicz, Z., Parfiniewicz, B., Weglarz, L., & Wilczok, T. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2463-6 · Cited by 95
Research works printed but not linked: 50
- Paridaens, 2003, Ann. Oncol., 14, 1391, 10.1093/annonc/mdg362 · DOI · Paper page
- Baum, 2002, Lancet, 359, 2131, 10.1016/S0140-6736(02)09088-8 · DOI · Paper page
- Ellis, 2003, J. Steroid Biochem. Mol. Biol., 86, 301, 10.1016/S0960-0760(03)00371-6 · DOI
- Geisler, 2003, J. Steroid Biochem. Mol. Biol., 86, 245, 10.1016/S0960-0760(03)00364-9 · DOI
- Miller, 2001, J. Steroid Biochem. Mol. Biol., 79, 93, 10.1016/S0960-0760(01)00148-0 · doi:10.1016/s0960-0760(01)00148-0
- Miller, 2003, J. Steroid Biochem. Mol. Biol., 86, 413, 10.1016/S0960-0760(03)00352-2 · DOI
- Simpson, 2001, Ann. N. Y. Acad. Sci., 949, 58, 10.1111/j.1749-6632.2001.tb04002.x · DOI · Paper page
- Ackerman, 1981, J. Clin. Endocrinol. Metab., 53, 412, 10.1210/jcem-53-2-412 · DOI · Paper page
- Price, 1992, J. Clin. Endocrinol. Metab., 74, 1247
- James, 1990, Ann. N. Y. Acad. Sci., 595, 227, 10.1111/j.1749-6632.1990.tb34296.x · DOI
- O'Neill, 1988, Br. Med. J., 296, 741, 10.1136/bmj.296.6624.741 · DOI · Paper page
- Bulun, 1993, J. Clin. Endocrinol. Metab., 77, 1622
- Yue, 1998, Cancer Res., 58, 927
- Mahendroo, 1993, J. Biol. Chem., 268, 19463, 10.1016/S0021-9258(19)36538-X · DOI · Paper page
- Zhao, 1995, Mol. Endocrinol., 9, 340
- Agarwal, 1996, J. Clin. Endocrinol. Metab., 81, 3843
- Zhou, 1996, J. Steroid Biochem. Mol. Biol., 59, 163, 10.1016/S0960-0760(96)00100-8 · DOI
- Harada, 1997, J. Steroid Biochem. Mol. Biol., 61, 175, 10.1016/S0960-0760(97)80010-6 · DOI
- Zhou, 1999, Arch. Biochem. Biophys., 371, 179, 10.1006/abbi.1999.1454 · DOI
- Zhao, 1996, Endocrinology, 137, 5739, 10.1210/endo.137.12.8940410 · doi:10.1210/endo.137.12.8940410 · Paper page
- Zhou, 2001, Cancer Res., 61, 2328
- Harada, 1998, Breast Cancer Res. Treat., 49, S15, 10.1023/A:1006076101178 · DOI
- McIntyre, 1991, Gastroenterology, 101, 1274, 10.1016/0016-5085(91)90077-X · DOI
- Weidle, 2000, Anticancer Res., 20, 1471
- Gore, 2000, Exp. Opin. Investig. Drugs, 9, 2923, 10.1517/13543784.9.12.2923 · DOI · Paper page
- Sowa, 2003, Nippon Eiseigaku Zasshi, 58, 267, 10.1265/jjh.58.267 · DOI
- Cuisset, 1997, J. Biol. Chem., 272, 24148, 10.1074/jbc.272.39.24148 · DOI
- Nichols, 1995, J. Soc. Gynecol. Investig., 2, 45, 10.1177/107155769500200109 · doi:10.1177/107155769500200109
- Zhao, 1995, J. Biol. Chem., 270, 16449, 10.1074/jbc.270.27.16449 · DOI · Paper page
- Meng, 2001, Cancer Res., 61, 2250
- Gurates, 2003, Mol. Cell. Endocrinol., 208, 61, 10.1016/S0303-7207(03)00198-9 · DOI
- Bulun, 1993, J. Clin. Endocrinol. Metabol., 77, 1616
- Cleland, 1983, Endocrinology, 113, 2155, 10.1210/endo-113-6-2155 · DOI · Paper page
- Hecht, 1996, Nature, 383, 92, 10.1038/383092a0 · DOI · Paper page
- Cosma, 1999, Cell, 97, 299, 10.1016/S0092-8674(00)80740-0 · DOI · Paper page
- Shaywitz, 1999, Annu. Rev. Biochem., 68, 821, 10.1146/annurev.biochem.68.1.821 · DOI · Paper page
- Simpson, 1994, Endocr. Rev., 15, 342
- Michael, 1997, Mol. Cell. Endocrinol., 134, 147, 10.1016/S0303-7207(97)00178-0 · DOI
- Jin, 2000, Breast Cancer Res. Treat., 62, 151, 10.1023/A:1006481228794 · DOI
- Zhou, 1998, Arch. Biochem. Biophys., 353, 213, 10.1006/abbi.1998.0641 · DOI
- Montminy, 1997, Annu. Rev. Biochem., 66, 807, 10.1146/annurev.biochem.66.1.807 · DOI · Paper page
- Maekawa, 1989, EMBO J., 8, 2023, 10.1002/j.1460-2075.1989.tb03610.x · DOI · Paper page
- Lee, 2001, Biochem. Biophys. Res. Commun., 281, 1241, 10.1006/bbrc.2001.4494 · DOI
- Shuman, 1997, J. Biol. Chem., 272, 12793, 10.1074/jbc.272.19.12793 · DOI · Paper page
- Mink, 1997, Mol. Cell. Biol., 17, 6609, 10.1128/MCB.17.11.6609 · DOI · Paper page
- Boffa, 1981, J. Biol. Chem., 256, 9612, 10.1016/S0021-9258(19)68806-X · DOI · Paper page
- Jung, 2005, Cancer Lett., 225, 199, 10.1016/j.canlet.2004.11.029 · DOI
- Cuisset, 1998, Biochem. Biophys. Res. Commun., 246, 760, 10.1006/bbrc.1998.8698 · DOI
- Schwartz, 1998, Mol. Cell. Biochem., 188, 21, 10.1023/A:1006831330340 · DOI
- Vernia, 2000, Dig. Dis. Sci., 45, 976, 10.1023/A:1005537411244 · DOI
Cited by
Aromatase, breast cancer and obesity: a complex interaction
Bulun, S. E., Chen, D., Moy, I., Brooks, D. C., & Zhao, H. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.10.003 · Cited by 224
“3/II is occupied by several transcriptional enhancers as a result of the activation of multiple signaling pathways that ultimately increase aro-matase expression in breast fibroblasts [43,44] (Figure 3).”
BackgroundSelf-citationAttar, E., Tokunaga, H., Imir, G., Yilmaz, M. B., Redwine, D., Putman, M., Gurates, B., Attar, R., Yaegashi, N., Hales, D. B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1180 · Cited by 207
Self-citationTrukhacheva, E., Lin, Z., Reierstad, S., Cheng, Y.-H., Milad, M., & Bulun, S. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1466 · Cited by 143
Self-citationGérard, C., & Brown, K. A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.014 · Cited by 136
Aromatase excess in cancers of breast, endometrium and ovary
Bulun, S. E., Chen, D., Lu, M., Zhao, H., Cheng, Y., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., et al. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.05.027 · Cited by 85
“3/II use in response to cAMP plus or minus PKC activation, the signaling pathways induced by PGE2 [29] [69].”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Deb, S., Zhou, J., Amin, S. A., Imir, A. G., Yilmaz, M. B., Lin, Z., & Bulun, S. E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 281
- Issue
- 5
- Pages
- 2585-2597
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2100392901
- Cited by
- 46
- References
- 9
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5359 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.